Similar articles

• Saralasin infusion in screening patients for renovascular hypertension.

  Krakoff LR, Ribeiro AB, Gorkin JU, Felton KR. Krakoff LR, et al. Am J Cardiol. 1980 Mar;45(3):609-13. doi: 10.1016/s0002-9149(80)80012-9. Am J Cardiol. 1980. PMID: 6986750
• Saralasin infusion in renovascular hypertension: increased response rate in seated patients.

  Tucker RM, Sheps SG, Brennan LA. Tucker RM, et al. Mayo Clin Proc. 1980 Feb;55(2):99-102. Mayo Clin Proc. 1980. PMID: 7354651
• Saralasin infusion in the recognition of renovascular hypertension.

  Wilson HM, Wilson JP, Slaton PE, Foster JH, Liddle GW, Hollifield JW. Wilson HM, et al. Ann Intern Med. 1977 Jul;87(1):36-42. doi: 10.7326/0003-4819-87-1-36. Ann Intern Med. 1977. PMID: 879617
• [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].

  Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A. Glorioso N, et al. Boll Soc Ital Cardiol. 1980;25(9):1035-46. Boll Soc Ital Cardiol. 1980. PMID: 7025868 Review. Italian. No abstract available.
• [The saralasin test in clinical evaluation of hypertensive states].

  Cremoncini C, Cremoncini M, Libroia A, Vignati E, Botalla L. Cremoncini C, et al. Boll Soc Ital Cardiol. 1978;23(8):1291-7. Boll Soc Ital Cardiol. 1978. PMID: 398708 Review. Italian. No abstract available.